Amphastar Pharmaceuticals' first quarter results saw revenue remain flat compared to last year and fall slightly short of Wall Street’s projections, while non-GAAP earnings per share came in ...

Avalyn Pharma has added on $100 million to accelerate novel inhaled versions of approved drugs for lung conditions. The ...

Despite these financial challenges, the company experienced a 20% increase in sales of Primatene Mist, indicating strong market demand.

Avalyn Pharma has drawn in another fundraising round, this time a $100 million oversubscribed series D to continue developing ...

U.S. Senator Maggie Hassan said on Friday she is launching an investigation into British pharmaceutical giant GlaxoSmithKline's decision to discontinue a widely used asthma inhaler for children.

HPE's must divest its Instant On business and Juniper will have to license its Mist AI software.

Joey Chestnut, a 16-time winner at the Nathan's Hot Dog Eating contest, reveals how he became the GOAT.

Meanwhile, the company highlighted growth in its branded products, with Primatene MIST sales rising 20% year-over-year, attributed to increased unit volumes and expanded physician outreach.

The researchers found that female permanent night shift workers had higher covariate-adjusted odds of moderate-to-severe asthma compared to female day workers (odds ratio, 1.50), but no ...

ProCare welcomes Pharmac’s announcement to improve access to some asthma inhalers and long-acting contraceptives from 1 August. The changes represent a significant step forward in supporting ...

US senator probes GSK’s halt of children’s asthma inhaler Economy Published 06/27/2025, 09:11 AM Updated 06/27/2025, 03:50 PM ...

The GINA 2025 asthma update includes new guidance on T2 biomarkers, asthma in young children, and climate change, as well as many updated charts and tools.